Oswell Penda Pharmaceutical Ltd

Information

Name

Type

Company

Roles

Supplier

Company Size

Sme

Company Number

Incorporation Date

Website

Address

Oswell Penda Pharmaceutical Ltd 106 Holme Lane Hillsborough, Sheffield, South Yorkshire, United Kingdom S6 4JW

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Oswell Penda Pharmaceutical Ltd
Sign up free

Contracts awarded to Oswell Penda Pharmaceutical Ltd

The contracts that Oswell Penda Pharmaceutical Ltd have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 3 days ago

Advanced Wound Care

The scope of this Framework is to cover the appropriate range of products to help influence ideal wound healing environments. The products are used to provide pathogen-free protection and/or moisten areas for healing of wounds to occur as well as prevent infection and skin breakages including, but not limited to Hydrogels, Gelling Fibres and Alginates, Wound Contact Layers, Super Absorbent Dressings, Dressing Pads, Foam Dressings, Hydrocolloid Dressings, Non-Woven Island Dressings, IV Dressings, Film and Film Island Dressings, Burns and Scar Management, Speciality Wound Care, Wound Irrigation, Debridement, Adhesive Removers, Barrier Creams and Films, Compression Bandages and Medical Adhesive Tapes. It is anticipated that initial expenditure for this Framework will be circa £250,960,973 GBP in the first year of this Framework Agreement. If the Framework Agreement is extended to the maximum duration, the anticipated expenditure will be circa £1,003,843,892 GBP to £1,467,008,032 GBP. These are approximates only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement

£1,467,008,032
Award

Published 3 days ago

CF CAN Advanced Wound Care

The scope of this Framework is to cover the appropriate range of products to help influence ideal wound healing environments. The products are used to provide pathogen-free protection and/or moisten areas for healing of wounds to occur as well as prevent infection and skin breakages including, but not limited to Hydrogels, Gelling Fibres and Alginates, Wound Contact Layers, Super Absorbent Dressings, Dressing Pads, Foam Dressings, Hydrocolloid Dressings, Non-Woven Island Dressings, IV Dressings, Film and Film Island Dressings, Burns and Scar Management, Speciality Wound Care, Wound Irrigation, Debridement, Adhesive Removers, Barrier Creams and Films, Compression Bandages and Medical Adhesive Tapes. The Framework Agreement will have an initial term of 24 months with an option to extend for up to a total period of 48 months. It is anticipated that initial expenditure for this Framework will be circa £250,960,973 GBP in the first year of this Framework Agreement. If the Framework Agreement is extended to the maximum duration, the anticipated expenditure will be circa £1,003,843,892 GBP to £1,467,008,032 GBP. These are approximates only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement

£1,467,008,032 Bids close: 8 months ago

Oswell Penda Pharmaceutical Ltd

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Oswell Penda Pharmaceutical Ltd

Advanced Wound Care

CF CAN Advanced Wound Care

Contacts

Statistics (1 Year)